Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Impact of Antibiotics on Microbiomes Post-mastectomy With Implant-based Breast Reconstruction
NCT05020574Phase 2Recruiting
- Sponsor
- University of California, San Francisco
- Start
- Sep 2021
- Primary completion
- Dec 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of cefalexin in surgical site infection (SSI), sponsored by University of California, San Francisco. Started Sep 2021; status: recruiting.
02
Drugs
cefalexin
03
Conditions
surgical site infection (SSI)
Beyond the preview
Go deeper on NCT05020574.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05020574.